Company intelligence / Profile preview

Stem Cell Implants

La Jolla, California, United Statesstemcell-implants.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Stem Cell Implants has not yet reported clinical trial results. The science is described as "ready," but the product remains under development with an aggressive timeline toward commercialization. The focus is on bringing lab-grown, infection-free bone tissue to chairside use for dentists.

Therapeutic areas: Other
Modalities: Pluripotent stem cells for regenerative medicineBone tissue engineering for dental implants and grafts
Industry: Biotech

Partnerships

Collaboration with Dr. Vernon from Arizona State University as Chief Science Officer; no major pharma partnerships disclosed yet.

Beyond the preview

Go deeper on Stem Cell Implants.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stem Cell Implants.

Explore the full profile